Retinol binding protein 4 (RBP4) is implicated in obesity, insulin resistance and type 2 diabetes mellitus that are closely associated with nonalcoholic fatty liver disease (NAFLD). This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatotic liver disease.